Project Name: Novartis Re-imagining Care Pathways Collaborative Working Project (“NRCP CWP”) North Bristol NHS Trust, Multiple Sclerosis Service
Project Summary:
The NRCP CWP is a service offered by Novartis, which comprises a series of workshops, with the aim of providing pathway mapping support to the CW Partner (healthcare and service teams) to:
- Improve efficiency and service effectiveness for the benefit of patient care.
- Address the local challenges in the delivery of patient care.
The programme facilitates area teams (Trust or Integrated Care System (ICS)) to identify areas for efficiency within their Multiple Sclerosis service for prioritisation. The CWP will be carried out in a number of different institutions. The service is facilitated by the Novartis Solutions Implementation Manager (SIM) Team.
Expected Benefits:
Anticipated benefits for patients
- Improvement of clinical pathways which may result in potentially fewer visits and shorter waiting times due to a more efficient clinical pathway.
- Enhanced patient experience of the NHS MS service by mapping the pathway which might allow the inefficiencies to be pinpointed and might allow for service improvement by reducing unnecessary waiting time and potentially reducing the number of visits.
- Potential quality care improvements aligned to established best practices.
Anticipated benefits for the organisation(s)
- Improved understanding of the current service pathway, and associated efficiencies and inefficiencies. Potential to lead to solutions which could allow the CW Partner’s healthcare and service teams to enhance both patient experience and outcomes.
Anticipated benefits for Novartis
- Understanding of possible opportunities to partner with the CW Partner to enhance patient outcomes and experience. Better understanding of patients,’ carers and customers’ needs, which may inform future service offerings, and synergies between needs of the customer and value of Novartis offerings.
Start Date & Duration: July 2025, 14 weeks
FA-11473068 | July 2025